JPS64949B2 - - Google Patents

Info

Publication number
JPS64949B2
JPS64949B2 JP55073815A JP7381580A JPS64949B2 JP S64949 B2 JPS64949 B2 JP S64949B2 JP 55073815 A JP55073815 A JP 55073815A JP 7381580 A JP7381580 A JP 7381580A JP S64949 B2 JPS64949 B2 JP S64949B2
Authority
JP
Japan
Prior art keywords
compound
formula
nhconh
nhso
nhcsnh
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP55073815A
Other languages
English (en)
Japanese (ja)
Other versions
JPS55164676A (en
Inventor
Beshaagen Horusuto
Yunge Boodo
Shutorutefuusu Yurugen
Shumitsuto Derufu
Peetaa Kurauze Hansu
Purusu Warutaa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of JPS55164676A publication Critical patent/JPS55164676A/ja
Publication of JPS64949B2 publication Critical patent/JPS64949B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Fodder In General (AREA)
JP7381580A 1979-06-05 1980-06-03 Novel 3*4*55trihydroxypiperidine compound Granted JPS55164676A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19792922760 DE2922760A1 (de) 1979-06-05 1979-06-05 Neue derivate von 3,4,5-trihydroxypiperidin, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel sowie in der tierernaehrung

Publications (2)

Publication Number Publication Date
JPS55164676A JPS55164676A (en) 1980-12-22
JPS64949B2 true JPS64949B2 (en]) 1989-01-10

Family

ID=6072499

Family Applications (1)

Application Number Title Priority Date Filing Date
JP7381580A Granted JPS55164676A (en) 1979-06-05 1980-06-03 Novel 3*4*55trihydroxypiperidine compound

Country Status (18)

Country Link
US (1) US4465684A (en])
EP (1) EP0019899B1 (en])
JP (1) JPS55164676A (en])
AT (1) ATE8500T1 (en])
AU (1) AU539847B2 (en])
CA (1) CA1146558A (en])
DE (2) DE2922760A1 (en])
DK (1) DK243280A (en])
ES (1) ES492143A0 (en])
FI (1) FI801787A7 (en])
GR (1) GR69267B (en])
HU (1) HU182143B (en])
IE (1) IE50258B1 (en])
IL (1) IL60210A (en])
NO (2) NO801553L (en])
PT (1) PT71308A (en])
SU (2) SU1017168A3 (en])
ZA (1) ZA803330B (en])

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56108767A (en) * 1980-01-28 1981-08-28 Nippon Shinyaku Co Ltd Bismoranoline derivative
US5015229A (en) * 1987-11-16 1991-05-14 Medicorp Holding S.A. Device for dispensing liquids
EP0344383A1 (en) * 1988-06-02 1989-12-06 Merrell Dow Pharmaceuticals Inc. Novel alpha-Glucosidase inhibitors
DE3936295A1 (de) * 1989-11-01 1991-05-02 Bayer Ag Verfahren zur herstellung von zwischenprodukten und zur synthese von n-(2-hydroxyethyl)-2-hydroxymethyl-3,4,5-trihydroxypiperidine
US5252587A (en) * 1990-04-27 1993-10-12 Merrell Dow Pharmaceuticals, Inc. N-derivatives of 1-deoxy nojirimycin
US5536732A (en) * 1990-04-27 1996-07-16 Merrell Pharmaceuticals Inc. N-derivatives of 1-deoxy nojirimycin
JPH0688963B2 (ja) * 1990-08-15 1994-11-09 工業技術院長 ジ（フェニル）スルホンスルホニルフルオライド化合物
AUPP942599A0 (en) * 1999-03-24 1999-04-15 Commonwealth Scientific And Industrial Research Organisation Antiviral agents
EP1575587A1 (en) * 2002-10-29 2005-09-21 Ranbaxy Laboratories, Ltd. Iminosugar derivatives as glucosidase inhibitors
WO2022011211A1 (en) * 2020-07-10 2022-01-13 Emergent Product Development Gaithersburg Inc. Deoxynojirimycin derivatives as glucosidase inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO154918C (no) * 1977-08-27 1987-01-14 Bayer Ag Analogifremgangsmaate til fremstilling av terapeutisk aktive derivater av 3,4,5-trihydroksypiperidin.
JPS56108767A (en) * 1980-01-28 1981-08-28 Nippon Shinyaku Co Ltd Bismoranoline derivative

Also Published As

Publication number Publication date
SU1050563A3 (ru) 1983-10-23
ATE8500T1 (de) 1984-08-15
AU539847B2 (en) 1984-10-18
DK243280A (da) 1980-12-06
US4465684A (en) 1984-08-14
AU5852580A (en) 1980-12-11
ZA803330B (en) 1981-06-24
NO801553L (no) 1980-12-08
FI801787A7 (fi) 1981-01-01
DE3068585D1 (en) 1984-08-23
GR69267B (en]) 1982-05-12
PT71308A (en) 1980-06-01
JPS55164676A (en) 1980-12-22
ES8102096A1 (es) 1980-12-16
EP0019899B1 (de) 1984-07-18
IE801149L (en) 1980-12-05
NO852778L (no) 1980-12-08
HU182143B (en) 1983-12-28
IL60210A0 (en) 1980-09-16
ES492143A0 (es) 1980-12-16
EP0019899A1 (de) 1980-12-10
DE2922760A1 (de) 1980-12-11
CA1146558A (en) 1983-05-17
SU1017168A3 (ru) 1983-05-07
IL60210A (en) 1983-11-30
IE50258B1 (en) 1986-03-19

Similar Documents

Publication Publication Date Title
FI72715C (fi) Foerfarande foer framstaellning av nya, terapeutiskt anvaendbara 2-hydroximetyl-3,4,5-trihydroxipiperidinderivat.
US4407809A (en) N-phenoxy(or thio)hydrocarbon 3,4,5-trihydroxypiperidine derivatives, their use in medicine and in animal nutrition
DE2758025A1 (de) Neue derivate von 3,4,5-trihydroxypiperidin, verfahren zu ihrer herstellung und ihre verwendung
US4278683A (en) Saccharase inhibiting 3,4,5-trihydroxypiperidine derivatives
JPS64949B2 (en])
US3715375A (en) New diphenyl sulfones
US4328233A (en) α-Glucosidase inhibiting 2-hydroxymethyl-3,4,5-trihydroxy-piperidines
US4293551A (en) N-Amino-3,4,5-trihydroxypiperidines, their production and their medicinal use
FI72716B (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 2-hydroximetyl-3,4,5-trihydroxipiperidinderivat.
DE2738717A1 (de) N-alkylierte derivate der 5-amino- 5-deoxy-d-glucose, verfahren zu ihrer herstellung und ihre verwendung
FI78468C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara 3,4,5-trihydroxipiperidinderivat.
DE2658562C2 (en])